Results 51 to 60 of about 2,196,135 (231)

Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients With coronary stent restenosis

, 2021
Background: In patients with coronary in-stent restenosis (ISR) requiring reintervention, it is unclear if the choice of treatment should depend on whether the restenotic stent was a bare-metal stent (BMS) or a drug-eluting stent (DES).Objectives: This ...
Leos Pleva (10865607), Fernando Alfonso (848316), Duk-Woo Park (796012), José P S Henriques (10865656), Adnan Kastrati (95640), Runlin Gao (715312), Jan Baan (4586296), Bo Xu (233514), Bimmer E P M Claessen (10865580), Ralf Degenhardt (10865599), Pilar Jiménez-Quevedo (5638394), Seung-Jung Park (95648), Pavel Kukla (10865626), Martin Unverdorben (10865644), Christoph K Naber (10865652), Tom Adriaenssens (397863), Daniele Giacoppo (10865563), María J Pérez-Vizcayno (10865592), Javier Cuesta (2653306), Christoph Jensen (2806795), Robert Byrne (8134437), Do-Yoon Kang (5958893)   +21 more
core   +1 more source

Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial.

The Lancet
BACKGROUND The long-term impact of drug-coated balloon (DCB) angioplasty for the treatment of patients with de novo coronary artery lesions remains uncertain. We aimed to assess the non-inferiority of DCB angioplasty with rescue stenting to intended drug-
Chao Gao, Xing-Qiang He, Fan Ouyang, Zhi-Hui Zhang, Guidong Shen, Mingxing Wu, Ping Yang, Likun Ma, Feng Yang, Zheng Ji, Hua Wang, Yan-Qing Wu, Zhen-Fei Fang, Hong Jiang, Shang-Yu Wen, Yi Liu, Fei Li, Jing-yu Zhou, Bin Zhu, Yun-Peng Liu, Rui-Ning Zhang, Tingting Zhang, Ping Wang, Jian-Zheng Liu, Zhi-Wei Jiang, Jielai Xia, R. V. van Geuns, D. Capodanno, S. Garg, Y. Onuma, Duo-Lao Wang, P. Serruys, Ling Tao   +32 more
semanticscholar   +1 more source

Soft Robotic Excretory Care Simulator for Nursing Education: Functional and Perceptual Biomimetics Approach

Advanced Robotics Research, EarlyView.
A soft robotic simulator is developed to replicate the digital removal of feces (DRF), a sensitive yet essential nursing procedure. Integrating soft actuators, sensors, and a realistic rectal model, the simulator balances functional fidelity with perceptual realism. Engineering evaluations and nurse feedback confirm its potential to enhance training in
Shoko Miyagawa, Sota Suzuki, Shizuka Watanabe, Zebing Mao, Young Ah Seong, Toshinori Fujie, Tatsuhiro Horii, Kenjiro Tadakuma, Koichi Suzumori, Hiroyuki Nabae, Shingo Maeda   +10 more
wiley   +1 more source

Efficacy and safety of the paclitaxel drug-coated balloon angioplasty for the treatment of coronary small vessel disease: a prospective, multicenter, randomized clinical trial

BMC Cardiovascular Disorders
Background The optimal revascularization strategy for coronary small vessel disease remains controversial due to limited lumen gain and high restenosis risk associated with stent implantation.
Mingduo Zhang, Shiqi Liu, Zhao Ma, Meichen Sun, Yifei Nie, Baoen Zhang, Min Zhang, Xiantao Song, Dongfeng Zhang   +8 more
doaj   +1 more source

Efficacy and Safety of TurboHawk Plaque Rotation Combined With Drug-coated Balloon in Treating Diabetic Patients With Lower Extremity Arterial Disease

Clinical and Applied Thrombosis/Hemostasis, 2020
To evaluate the efficacy and safety of TurboHawk plaque rotation system combined with drug-coated balloon in treating lower extremity arterial disease (LEAD) of diabetes patients, a total of 145 diabetic patients with LEAD from March 2015 to September ...
Kehua Wang MM, Ying Li MM, Fengli Gao MM, Haiwen Gong MM, Xueru Li MM, Xiaolu Ren MM   +5 more
doaj   +1 more source

Basic Concepts and Clinical Outcomes of Drug-Eluting Balloons for Treatment of Coronary Artery Disease: An Overview [PDF]

Journal of Clinical and Diagnostic Research, 2017
The technology of percutaneous coronary intervention for atherosclerotic coronary artery disease has evolved considerably since its inception. Though Drug-Eluting Stent (DES) reduces the rate of restenosis, long-term safety outcomes and persistent ...
C. D. Ramakrishna, Bhargav A. Dave, Pankaj S. Kothavade, Kajal J. Joshi, Ashok S. Thakkar   +4 more
doaj   +1 more source

Cross‐Scale Hierarchical Targeted Delivery System Based on Small‐Scale Magnetic Robots

Advanced Robotics Research, EarlyView.
This article reviews a cross‐scale hierarchical targeted delivery system that integrates magnetic continuum robots and magnetic microrobots. By combining rapid long‐range navigation with precise microscale targeting, the system overcomes key limitations of single‐scale approaches.
Junjian Zhou, Zhiqiang Chen, Yuanbiao Ma, Zhiqiang Tang, Qianqian Wang   +4 more
wiley   +1 more source

Efficacy of the Optilume paclitaxel drug-coated balloon after urethroplasty: short-term results from a multicenter study

Therapeutic Advances in Urology
Background: The Optilume® paclitaxel drug-coated balloon (DCB) is a relatively new-to-market alternative in the management of male anterior urethral stricture disease.
M. VanDyke, Eshan G. Joshi, B. Ceballos, A. Baumgarten, Ethan L. Matz, Kayla S. Graham, M. Mckibben, A. Imam, Lucas Wiegand, Bryce P. Franzen, Steven J. Hudak   +10 more
semanticscholar   +1 more source

Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis

Advanced Science, EarlyView.
Why does fat accumulate in the liver? Our study reveals Rab1A as the molecular switch that silences the cell's mitochondrial cleanup crew. Turning Rab1A off reactivates mitophagy, clears excess fat, and reverses fatty liver disease in mice—offering a promising new therapeutic target for MASLD, a growing global health challenge.
Li Zhang, Jianhua Li, Huilu Zhang, Qi Qin, Yichen Huang, Xiaofan Tian, Chao Sun, Binbin Li, Zhengxin Wang, Xin Zhang   +9 more
wiley   +1 more source

Drug-coated balloon used to treat in-stent restenosis of the renal artery

, 2018
During recent years, drug-coated balloons (DCBs) have emerged as a promising therapeutic option. DCBs directly transfer antiproliferative drugs to the arterial wall in order to decrease myointimal hyperplasia.
Winston Bonetti Yoshida (4647160), Regina Moura (4647166), Ricardo de Alvarenga Yoshida (5221892), Jamil Victor de Oliveira Mariúba (5221889), Marcone Lima Sobreira (4647163), Matheus Bertanha (4647151), Rodrigo Gibin Jaldin (577486), Rafael Elias Fares Pimenta (5221886)   +7 more
core   +1 more source